Menzel Garry E 4
4 · Stoke Therapeutics, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Menzel Garry E
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-06-13+19,441→ 19,441 totalExercise: $12.46Exp: 2033-06-12→ Common Stock (19,441 underlying)
Footnotes (1)
- [F1]The option shall fully vest on June 13, 2024 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.